Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Return on Invested Capital (2019 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Return on Invested Capital for 7 consecutive years, with 0.19% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Invested Capital rose 47.0% to 0.19% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.19%, a 47.0% increase, with the full-year FY2024 number at 0.06%, down 19.0% from a year prior.
  • Return on Invested Capital was 0.19% for Q3 2025 at Xtant Medical Holdings, up from 0.16% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.19% in Q3 2025 to a low of 0.85% in Q3 2023.
  • A 5-year average of 0.1% and a median of 0.1% in 2022 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: surged 132bps in 2021, then crashed -72bps in 2023.
  • Xtant Medical Holdings' Return on Invested Capital stood at 0.05% in 2021, then tumbled by -243bps to 0.17% in 2022, then skyrocketed by 165bps to 0.11% in 2023, then tumbled by -158bps to 0.07% in 2024, then skyrocketed by 389bps to 0.19% in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Return on Invested Capital are 0.19% (Q3 2025), 0.16% (Q2 2025), and 0.02% (Q1 2025).